Načítá se...
Emerging medical therapies for non-alcoholic fatty liver disease and for alcoholic hepatitis
Non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) are currently the two most common liver diseases in the world. Alcoholic hepatitis (AH), a unique clinical syndrome among ALD patients has high short-term mortality. Apart from controlling the risk factor for individual resp...
Uloženo v:
| Vydáno v: | Transl Gastroenterol Hepatol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6691078/ https://ncbi.nlm.nih.gov/pubmed/31463412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2019.06.06 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|